Contergan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1961-2016
0119612016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Im dem vorliegenden Text wird ein Überblick über theoretische Ansätze, Überlegungen und empirische Befunde zur Lebenssituation… (More)
Is this relevant?
Review
2009
Review
2009
Im vorliegenden Beitrag wird ein Überblick über die Lebenssituation von Contergan-geschädigten Menschen gegeben. Das Ziel des… (More)
Is this relevant?
2009
2009
CASE REPORT A 47 year old female with severe deficiency of three limbs visited our Genetic Counselling Clinic and asked us to… (More)
Is this relevant?
2009
2009
Aufgrund des steigenden Alters Schwangerer ist eine zunehmende Anzahl an Patientinnen mit Mammakarzinom bei gleichzeitig… (More)
Is this relevant?
2008
2008
There is something brewing in the field of toxicology: Last year's vision and strategy document published by the US National… (More)
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2002
2002
The first paper describing the pharmacological actions of thalidomide was published in 1956. The drug, then designated as K17… (More)
Is this relevant?
Review
2002
Review
2002
Thalidomide was first introduced to the market in Germany under the brand name of Contergan in 1956, as a non-barbiturate… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1995
1995
Reversed-phase liquid chromatography is a long established method for the analysis of drug metabolism. The current investigation… (More)
Is this relevant?
Review
1988
Review
1988
The year 1986 was the 25th anniversary of the recognition that thalidomide is a potent human teratogen, and our president, Lewis… (More)
Is this relevant?
1961
1961
 
Is this relevant?